Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dave Morgan

Showing results (51-60 of 89) with videos related to

Pageof 9
Sort By:
Journal of Neuroscience Methods|October 19, 2010
Convection-enhanced delivery and systemic mannitol increase gene product distribution of AAV vectors 5, 8, and 9 and increase gene product in the adult mouse brainNikisha Carty, Daniel Lee, Chad Dickey, et al.
Scientific Reports|October 22, 2024
Validation of a functional human AD model with four AD therapeutics utilizing patterned ipsc-derived cortical neurons integrated with microelectrode arraysJulbert Caneus, Kaveena Autar, Nesar Akanda, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 28, 2007
Microglial activation is required for Abeta clearance after intracranial injection of lipopolysaccharide in APP transgenic miceDonna L Herber, Mary Mercer, Lisa M Roth, et al.
Journal of Neuroinflammation|May 12, 2006
Intracranial administration of deglycosylated C-terminal-specific anti-Abeta antibody efficiently clears amyloid plaques without activating microglia in amyloid-depositing transgenic miceNiki C Carty, Donna M Wilcock, Arnon Rosenthal, et al.
Journal of Alzheimer'S Disease : JAD|December 20, 2008
Apparent behavioral benefits of tau overexpression in P301L tau transgenic miceDave Morgan, Sanjay Munireddy, Jennifer Alamed, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|December 27, 2011
Chronological age impacts immunotherapy and monocyte uptake independent of amyloid loadQingyou Li, Lori Lebson, Daniel C Lee, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 19, 2006
Deglycosylated anti-amyloid-beta antibodies eliminate cognitive deficits and reduce parenchymal amyloid with minimal vascular consequences in aged amyloid precursor protein transgenic miceDonna M Wilcock, Jennifer Alamed, Paul E Gottschall, et al.
Plos One|April 5, 2013
Intracranial injection of AAV expressing NEP but not IDE reduces amyloid pathology in APP+PS1 transgenic miceNikisha Carty, Kevin R Nash, Milene Brownlow, et al.
Stem Cell Reports|December 23, 2021
A functional hiPSC-cortical neuron differentiation and maturation model and its application to neurological disordersKaveena Autar, Xiufang Guo, John W Rumsey, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 16, 2002
Microglial activation and beta -amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic micePaul T Jantzen, Karen E Connor, Giovanni DiCarlo, et al.
Pageof 9

Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
Journal of Neuroscience Methods|October 19, 2010
Convection-enhanced delivery and systemic mannitol increase gene product distribution of AAV vectors 5, 8, and 9 and increase gene product in the adult mouse brainNikisha Carty, Daniel Lee, Chad Dickey, et al.
Scientific Reports|October 22, 2024
Validation of a functional human AD model with four AD therapeutics utilizing patterned ipsc-derived cortical neurons integrated with microelectrode arraysJulbert Caneus, Kaveena Autar, Nesar Akanda, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 28, 2007
Microglial activation is required for Abeta clearance after intracranial injection of lipopolysaccharide in APP transgenic miceDonna L Herber, Mary Mercer, Lisa M Roth, et al.
Journal of Neuroinflammation|May 12, 2006
Intracranial administration of deglycosylated C-terminal-specific anti-Abeta antibody efficiently clears amyloid plaques without activating microglia in amyloid-depositing transgenic miceNiki C Carty, Donna M Wilcock, Arnon Rosenthal, et al.
Journal of Alzheimer'S Disease : JAD|December 20, 2008
Apparent behavioral benefits of tau overexpression in P301L tau transgenic miceDave Morgan, Sanjay Munireddy, Jennifer Alamed, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|December 27, 2011
Chronological age impacts immunotherapy and monocyte uptake independent of amyloid loadQingyou Li, Lori Lebson, Daniel C Lee, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 19, 2006
Deglycosylated anti-amyloid-beta antibodies eliminate cognitive deficits and reduce parenchymal amyloid with minimal vascular consequences in aged amyloid precursor protein transgenic miceDonna M Wilcock, Jennifer Alamed, Paul E Gottschall, et al.
Plos One|April 5, 2013
Intracranial injection of AAV expressing NEP but not IDE reduces amyloid pathology in APP+PS1 transgenic miceNikisha Carty, Kevin R Nash, Milene Brownlow, et al.
Stem Cell Reports|December 23, 2021
A functional hiPSC-cortical neuron differentiation and maturation model and its application to neurological disordersKaveena Autar, Xiufang Guo, John W Rumsey, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 16, 2002
Microglial activation and beta -amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic micePaul T Jantzen, Karen E Connor, Giovanni DiCarlo, et al.
Pageof 9